SEC
SlamSEC
SearchBrowseEarnings

AGENUS INC

Nasdaq:AGEN
Biological Products, (No Diagnostic Substances)·LEXINGTON, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer.

Revenue
$98.0M
-66.8% YoY
FY 2024
Adj. EBITDA
-$172.5M
-176.0% margin
FY 2024
Net Income
$17.4M
17.8% margin
FY 2020
EPS (Diluted)
-$15.64
FY 2024
Stock Price
$3.10
+4.0%
2026-03-13
52W Range
$1.38 – $7.34
P/E Ratio
-0.2x
Market Cap
$105.4M
Cash
$178.7M
FY 2024
Total Debt
$12.8M
FY 2024
Net Cash
$165.9M
FY 2024
Enterprise Value
-$60.5M
Debt / EBITDA
1.0x
FY 2024
EV / EBITDA
0.4x
Employees
—